Purple Biotech
PPBT

Purple Biotech (PPBT) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$17.00 from $30.00Aug 7, 2026
HC Wainwright & Co.MaintainedBuy$30.00 from $34.00Mar 13, 2026
HC Wainwright & Co.MaintainedBuy$33.00Nov 15, 2024
HC Wainwright & Co.MaintainedBuy$33.00 from $8.00Sep 20, 2024
HC Wainwright & Co.MaintainedBuy$8.00 from $10.00Aug 19, 2024
HC Wainwright & Co.MaintainedBuy$10.00Jul 11, 2024
HC Wainwright & Co.MaintainedBuy$10.00May 21, 2024
HC Wainwright & Co.MaintainedBuy$10.00Apr 26, 2024
Chardan CapitalMaintainedBuy$11.00Mar 7, 2024
HC Wainwright & Co.MaintainedBuy$10.00Mar 5, 2024
HC Wainwright & Co.MaintainedBuy$10.00Feb 27, 2024
HC Wainwright & Co.MaintainedBuy$10.00 from $9.00Nov 21, 2023
HC Wainwright & Co.MaintainedBuy$9.00 from $7.00Aug 31, 2023
HC Wainwright & Co.MaintainedBuy$9.00 from $7.00Aug 30, 2023
JonesTradingInitiated CoverageBuy$8.00Jul 21, 2023
Chardan CapitalMaintainedBuy$11.00May 17, 2023
HC Wainwright & Co.MaintainedBuy$7.00May 17, 2023

Frequently asked questions

  • What is the latest analyst rating on PPBT?

    On Aug 7, 2026, HC Wainwright & Co. maintained Purple Biotech at Buy with a price target of $17.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.